Related Experiment Video
Updated: Aug 8, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
[Relation between lupus-antiphospholipids antibodies and heart disorders]
1Service d'hématologie et d'immunologie, Hôpital Aristide le Dantec, Dakar, Sénégal. awaoumar2000@yahoo.fr
Annales De Biologie Clinique
|May 16, 2006
Summary
Antiphospholipid antibodies (APL) are not an independent risk factor for cardiac disorders in patients with systemic lupus erythematosus. This study found no increased cardiac risk in APL-positive lupus patients compared to APL-negative individuals.
Area of Science:
- Rheumatology and Immunology
- Cardiology
- Clinical Research
Context:
- Systemic lupus erythematosus (SLE) is an autoimmune disease with variable prevalence of antiphospholipid antibodies (APL).
- Previous reports suggest a potential link between APL and cardiac complications in lupus patients.
- The exact role of APL as an independent risk factor for cardiac disorders in SLE remains unclear.
Purpose:
- To investigate the association between antiphospholipid antibodies (APL) and cardiac disorders in patients with systemic lupus erythematosus (SLE).
- To determine if APL seropositivity independently predicts the risk of developing cardiac abnormalities in SLE patients.
Summary:
- A prospective study included 37 SLE patients, with 8 (14.6%) testing positive for APL and 20 presenting cardiac abnormalities.
- Analysis revealed no statistically significant difference in cardiac disease risk between APL-positive and APL-negative lupus patients (p=1).
- Platelet count and activated partial thromboplastin time were also assessed.
Impact:
- This research suggests that antiphospholipid antibodies may not be an independent risk factor for heart disease in individuals with systemic lupus erythematosus.
- Findings contribute to a better understanding of cardiac risk stratification in SLE patients.
- Highlights the need for further research to elucidate the complex relationship between autoimmunity and cardiovascular health in lupus.
Related Concept Videos
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...